EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Associations of Clinical and Dosimetric Parameters with Urinary Toxicities after Prostate Brachytherapy: A Long-Term Single-Institution Experience

Masaya Ito iD, Chiyoko Makita, Takayuki Mori iD, Hirota Takano, Tomoyasu Kumano, Masayuki Matsuo, Koji Iinuma iD, Makoto Kawase iD, Keita Nakane, Masahiro Nakano, Takuya Koie iD

Current Oncology · 2023

DOI: 10.3390/curroncol30060426 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, 2023. Verfasst von Masaya Ito und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Gifu Takayama Red Cross Hospital, 3-11, Tenmancho, Takayama City 500-8717, Gifu, Japan. Hauptthemen laut MEDLINE: Brachytherapy, Urinary Bladder, Overactive, Lower Urinary Tract Symptoms, Prostatic Neoplasms. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To examine the association of clinical, treatment, and dose parameters with late urinary toxicity after low-dose-rate brachytherapy (LDR-BT) for prostate cancer, we retrospectively studied patients with prostate cancer who underwent LDR-BT from January 2007 through December 2016. Urinary toxicity was assessed using the International Prostate Symptom Score (IPSS) and Overactive Bladder (OAB) Symptom Score (OABSS). Severe and moderate lower urinary tract symptoms (LUTS) were defined as IPSS ≥ 20 and ≥ 8, respectively; OAB was defined as a nocturnal frequency of ≥ 2 and a total OABSS of ≥ 3. In total, 203 patients (median age: 66 years) were included, with a mean follow-up of 8.4 years after treatment. The IPSS and OABSS worsened after 3 months of treatment; these scores improved to pretreatment levels after 18–36 months in most patients. Patients with a higher baseline IPSS and OABSS had a higher frequency of moderate and severe LUTS and OAB at 24 and 60 months, respectively. LUTS and OAB at 24 and 60 months were not correlated with the dosimetric factors of LDR-BT. Although the rate of long-term urinary toxicities assessed using IPSS and OABSS was low, the baseline scores were related to long-term function. Refining patient selection may further reduce long-term urinary toxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrachytherapyUrinary Bladder, OveractiveLower Urinary Tract SymptomsProstatic NeoplasmsMaleHumansAgedProstateRetrospective Studies

Stichwörter der Autor:innen

brachytherapyinternational prostate symptom score (IPSS)lower urinary tract symptomsoveractive bladder symptom score (OABSS)prostate cancer

Autor:innen und Institutionen

  • Department of Radiation Oncology, Gifu Takayama Red Cross Hospital, 3-11, Tenmancho, Takayama City 500-8717, Gifu, Japan.
  • Department of Radiology, Gifu University Hospital, 1-1, Yanagido, Gifu City 500-1194, Gifu, Japan.
  • Department of Urology, Gifu University Hospital, 1-1, Yanagido, Gifu City 500-1194, Gifu, Japan.
  • Department of Urology, Gifu Prefectural General Medical Center, 4-6-1, Noisshiki, Gifu City 500-8717, Gifu, Japan.

ORCID-Profile: Masaya Ito, Takayuki Mori, Koji Iinuma, Makoto Kawase, Takuya Koie

Zitieren

APA

Ito, M., Makita, C., Mori, T., Takano, H., Kumano, T., Matsuo, M., Iinuma, K., Kawase, M., Nakane, K., Nakano, M., & Koie, T. (2023). Associations of Clinical and Dosimetric Parameters with Urinary Toxicities after Prostate Brachytherapy: A Long-Term Single-Institution Experience. Current Oncology. https://doi.org/10.3390/curroncol30060426

Vancouver

Ito M, Makita C, Mori T, Takano H, Kumano T, Matsuo M, et al. Associations of Clinical and Dosimetric Parameters with Urinary Toxicities after Prostate Brachytherapy: A Long-Term Single-Institution Experience. Current Oncology. 2023. doi:10.3390/curroncol30060426

BibTeX
@article{Ito2023,
  author = {Ito, Masaya and Makita, Chiyoko and Mori, Takayuki and Takano, Hirota and Kumano, Tomoyasu and Matsuo, Masayuki and Iinuma, Koji and Kawase, Makoto and Nakane, Keita and Nakano, Masahiro and Koie, Takuya},
  title = {Associations of Clinical and Dosimetric Parameters with Urinary Toxicities after Prostate Brachytherapy: A Long-Term Single-Institution Experience},
  journal = {Current Oncology},
  year = {2023},
  doi = {10.3390/curroncol30060426}
}
Kostenlos starten →